×
RAPS Learning Portal will be under maintenance on 12 June 2026 between 10 PM - 12 AM ET. Learning Portal functionality and profile access may be unavailable during this window.
We apologize for any inconvenience caused during this time.

rf-fullcolor.png

 

31 May 2012
by RAPS

South Korean Regulators Increase Online Data Transparency

South Korea's Korean Food and Drug Administration (KFDA) has announced the re-launch of its website, which now includes consolidated drug information covering all drugs manufactured in South Korea.

The website now features a sub-page, drug.kfda.go.kr, which allows for the public to "retrieve and utilize a variety of drug information," including drug safety, drug effects, drug development assistance, information on pharmaceutical excipients, drug use and more. Additional information covers whether a product is KFDA-approved or covered by Korea's health insurers.

KFDA said the website renovation was part of its "efforts to more actively promote safe and effective use of medications by enabling easier access of the public to drug related information including its side-effects, recommended dosage and special precautions."


Read more:

KFDA - Newly renovated website brings in information service on domestically produced drugs

KFDA - drug.kfda.go.kr